Tauns Laboratories (TSE:197A) Scaled Net Operating Assets: 0.90 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:197A Tauns Laboratories Inc TSE:197A
14 GF Score
Price 円484.00
! 6 Warning Signs
View Full Analysis

What is Tauns Laboratories Scaled Net Operating Assets?

Tauns Laboratories TSE:197A -0.82% 14 Scaled Net Operating Assets is 0.90 as of Dec. 2025. GuruFocus rates TSE:197A with a GF Score™ of 14/100. The stock has 6 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Tauns Laboratories's operating assets for the quarter that ended in Dec. 2025 was 円39,943 Mil. Tauns Laboratories's operating liabilities for the quarter that ended in Dec. 2025 was 円4,641 Mil. Tauns Laboratories's Total Assets for the quarter that ended in Sep. 2025 was 円39,084 Mil. Therefore, Tauns Laboratories's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2025 was 0.90.

Tauns Laboratories Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Tauns Laboratories's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tauns Laboratories Scaled Net Operating Assets Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Scaled Net Operating Assets
0.29 0.68 0.75 0.77

Tauns Laboratories Quarterly Data
Jun22 Jun23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.63 0.60 0.83 0.90 0.73

TSE:197A vs ISRG, BDX, MDLN: Scaled Net Operating Assets Comparison

For the Medical Instruments & Supplies subindustry, Tauns Laboratories's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tauns Laboratories Scaled Net Operating Assets vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tauns Laboratories's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Tauns Laboratories's Scaled Net Operating Assets falls into.


TSE:197A
14GF Score
Tauns Laboratories Inc TSE:197A
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tauns Laboratories Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Tauns Laboratories's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Jun. 2025 )
=(Operating Assets (A: Jun. 2025 )-Operating Liabilities (A: Jun. 2025 ))/Total Assets (A: Jun. 2024 )
=(27248.664-4673.627)/29261.325
=0.77

where

Operating Assets(A: Jun. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=36515.294 - 9266.63
=27248.664

Operating Liabilities(A: Jun. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=19097.627 - 8809.081 - 5614.919
=4673.627

Tauns Laboratories's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2025 )
=(Operating Assets (Q: Dec. 2025 )-Operating Liabilities (Q: Dec. 2025 ))/Total Assets (Q: Sep. 2025 )
=(39943.409-4641.399)/39084.063
=0.90

where

Operating Assets(Q: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=44198.627 - 4255.218
=39943.409

Operating Liabilities(Q: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=26792.655 - 12868.088 - 9283.168
=4641.399

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.90 mean?
Tauns Laboratories (TSE:197A) has a Scaled Net Operating Assets of 0.90 as of Dec. 2025. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Tauns Laboratories and its competitors.
Is Tauns Laboratories' Scaled Net Operating Assets too high?
Tauns Laboratories' current Scaled Net Operating Assets is 0.90. Overall, Tauns Laboratories has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Tauns Laboratories' Scaled Net Operating Assets compare to ISRG and BDX?
Tauns Laboratories' Scaled Net Operating Assets of 0.90 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Devices & Instruments company?
A good Scaled Net Operating Assets depends on the Medical Devices & Instruments industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Tauns Laboratories and its competitors. Tauns Laboratories's current Scaled Net Operating Assets is 0.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tauns Laboratories stock overvalued right now?
Tauns Laboratories (TSE:197A) has a current Scaled Net Operating Assets of 0.90. The current Scaled Net Operating Assets is 0.90. Tauns Laboratories' overall GF Score™ is 14/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Tauns Laboratories (TSE:197A), the current Scaled Net Operating Assets is 0.90 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tauns Laboratories Business Description

Address 761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.
14GF Score

Get the complete analysis for TSE:197A

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円484.00
Price